25(OH)-Vitamin D alleviates neonatal infectious pneumonia via regulating TGFβ-mediated nuclear translocation mechanism of YAP/TAZ

References

• Liu J, Liu F, Liu Y, et al. Lung ultrasonography for the diagnosis of severe neonatal pneumonia. Chest. 2014;146(2):383–388.
   PubMed Web of Science ®Google Scholar
• Okumura T, Kawada JI, Tanaka M, et al. Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect Chemother. 2019;25(5):346–350.
   PubMed Web of Science ®Google Scholar
• Mathur S, Fuchs A, Bielicki J, et al. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health. 2018;38(sup1):S66–S75.
   PubMed Web of Science ®Google Scholar
• Shan LS, Liu X, Kang XY, et al. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children. World J Pediatr. 2017;13(4):321–327.
   PubMed Web of Science ®Google Scholar
• Stout A, Friedly J, Standaert CJ. Systemic absorption and side effects of locally injected glucocorticoids. PM R. 2019;11(4):409–419.
   PubMedGoogle Scholar
• Langdon A, Crook N, Dantas G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 2016;8(1):39.
   PubMed Web of Science ®Google Scholar
• Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, et al. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol. 2009;19:139–145.
   PubMed Web of Science ®Google Scholar
• Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies. Medicine (Baltimore). 2019;98(38):e17252.
   PubMed Web of Science ®Google Scholar
• Brenner H, Schottker B.Vitamin D insufficiency may account for almost nine of ten covid-19 deaths: time to act. comment on: “vitamin d deficiency and outcome of COVID-19 patients” nutrients .Nutrients.2020;12(12):2757; 2020, 12
   PubMed Web of Science ®Google Scholar
• Bizzaro G, Antico A, Fortunato A, et al. Vitamin D and autoimmune diseases: is vitamin d receptor (VDR) polymorphism the culprit? Isr Med Assoc J. 2017;19:438–443.
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Theodor E, Segal RM, et al. Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol. 2013;45(2):256–266.
   PubMed Web of Science ®Google Scholar
• Bover J, Egido J, Fernandez-Giraldez E, et al. D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease. Nefrologia. 2015;35:28–41.
   PubMed Web of Science ®Google Scholar
• El-Fakhri N, McDevitt H, Shaikh MG, et al. Vitamin D and its effects on glucose homeostasis, cardiovascular function and immune function. Horm Res Paediatr. 2014;81(6):363–378.
   PubMed Web of Science ®Google Scholar
• Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116(8):2062–2072.
   PubMed Web of Science ®Google Scholar
• Takeda S, Yoshizawa T, Nagai Y, et al. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology. 1999;140(2):1005–1008.
   PubMed Web of Science ®Google Scholar
• Chang E. 1,25-Dihydroxyvitamin D decreases tertiary Butyl-hydrogen peroxide-induced oxidative stress and Increases AMPK/SIRT1 activation in C2C12 muscle cells. Molecules. 2019;24(21). DOI:10.3390/molecules24213903
   Web of Science ®Google Scholar
• Heulens N, Korf H, Mathyssen C, et al. 1,25-Dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages. PLoS One. 2016;11(8):e0160482.
   PubMed Web of Science ®Google Scholar
• Deluca HF. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014;3:479.
   PubMedGoogle Scholar
• Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726–776.
   PubMed Web of Science ®Google Scholar
• Ito I, Waku T, Aoki M, et al. A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest. 2013;123(11):4579–4594.
   PubMed Web of Science ®Google Scholar
• Gough NR. Enhancing and Inhibiting TGF-β Signaling in Infection. Sci Signal. 2015;8(359):ec9–ec9.
   Google Scholar
• Pefani DE, Pankova D, Abraham AG, et al. O.N. TGF-beta targets the hippo pathway scaffold RASSF1A to facilitate YAP/SMAD2 nuclear translocation. Mol Cell. 2016;63(1):156–166.
   PubMed Web of Science ®Google Scholar
• LaCanna R, Liccardo D, Zhang P, et al. Yap/Taz regulate alveolar regeneration and resolution of lung inflammation. J Clin Invest. 2019;129(5):2107–2122.
   PubMed Web of Science ®Google Scholar
• Hagenbeek TJ, Webster JD, Kljavin NM, et al. The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumors. Sci Signal. 2018;11(547). 10.1126/scisignal.aaj1757
   PubMed Web of Science ®Google Scholar
• Koo HJ, Lim S, Choe J, et al. Radiographic and CT Features of Viral Pneumonia. Radiographics. 2018;38(3):719–739.
   PubMed Web of Science ®Google Scholar
• Hooven TA, Polin RA. Pneumonia. Semin Fetal Neonatal Med. 2017 Aug;22(4):206–213. doi:10.1016/j.siny.2017.03.002. Epub 2017 Mar 24. PMID: 28343909; PMCID: PMC7270051.
   Google Scholar
• Mizgerd JP. Pathogenesis of severe pneumonia: advances and knowledge gaps. Curr Opin Pulm Med. 2017;23(3):193–197.
   PubMed Web of Science ®Google Scholar
• Maldonado RF, Sa-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev. 2016;40(4):480–493.
   PubMed Web of Science ®Google Scholar
• Zhang J, Mao F, Zhao G, et al. Long non-coding RNA SNHG16 promotes lipopolysaccharides-induced acute pneumonia in A549 cells via targeting miR-370-3p/IGF2 axis. Int Immunopharmacol. 2020;78:106065.
   PubMed Web of Science ®Google Scholar
• Li Y, Li H, Liu S, et al. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Mol Immunol. 2018;99:134–144.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu Y, Gao G, et al. Knockdown XIST alleviates LPS-induced WI-38 cell apoptosis and inflammation injury via targeting miR-370-3p/TLR4 in acute pneumonia. Cell Biochem Funct. 2019;37(5):348–358.
   PubMed Web of Science ®Google Scholar
• Rashwan NI, Hassan MH, Mohey El-Deen ZM, et al. Validity of biomarkers in screening for neonatal sepsis - A single center -hospital based study. Pediatr Neonatol. 2019;60(2):149–155.
   PubMed Web of Science ®Google Scholar
• Cao WH, Su YJ, Liu NQ, et al. Role of Ca(2)(+) in inhibiting ischemia-induced apoptosis of parathyroid gland cells in new zealand white rabbits. Med Sci Monit. 2020;26:e920546.
   PubMed Web of Science ®Google Scholar
• Chen L, Eapen MS, Zosky GR. Vitamin D both facilitates and attenuates the cellular response to lipopolysaccharide. Sci Rep. 2017;7(1):45172.
   PubMedGoogle Scholar
• Zuo J, Hu Z, Liu T, et al. Calpeptin attenuates cigarette smoke-induced pulmonary inflammation via suppressing calpain/IkappaBalpha signaling in mice and BEAS-2B cells. Pathol Res Pract. 2018;214(8):1199–1209.
   PubMed Web of Science ®Google Scholar
• Song LN, Qiao GL, Yu J, et al. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. J Exp Clin Cancer Res. 2020;39(1):114.
   PubMed Web of Science ®Google Scholar
• Futakuchi A, Inoue T, Wei FY, et al. YAP/TAZ are essential for TGF-beta2-mediated conjunctival fibrosis. Invest Ophthalmol Vis Sci. 2018;59(7):3069–3078.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Meng F, Chen S, et al. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade. Nat Cell Biol. 2017;19(4):362–374.
   PubMed Web of Science ®Google Scholar
• Bian F, Wu YE, Zhang CL. Variation in the levels of IL-6 in pediatric patients with severe bacterial infectious diseases and correlation analysis between the levels of IL-6 and procalcitonin. Exp Ther Med. 2017;13(6):3484–3488.
   PubMed Web of Science ®Google Scholar
• Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107(3):370–371.
   PubMed Web of Science ®Google Scholar
• Yukioka H, Yoshida G, Kurita S, et al. Plasma procalcitonin in sepsis and organ failure. Ann Acad Med Singap. 2001;30:528–531.
   PubMed Web of Science ®Google Scholar
• Tauseef M, Knezevic N, Chava KR, et al. TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation. J Exp Med. 2012;209(11):1953–1968.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
   PubMed Web of Science ®Google Scholar
• Li W, Cheng X, Guo L, et al. Association between serum 25-hydroxyvitamin D concentration and pulmonary infection in children. Medicine (Baltimore). 2018;97(1):e9060.
   PubMed Web of Science ®Google Scholar
• Mohamed WA, Al-Shehri MA. Cord blood 25-hydroxyvitamin D levels and the risk of acute lower respiratory tract infection in early childhood. J Trop Pediatr. 2013;59(1):29–35.
   PubMed Web of Science ®Google Scholar
• Science M, Maguire JL, Russell ML, et al. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis. 2013;57(3):392–397.
   PubMed Web of Science ®Google Scholar
• Camargo CA Jr., Ingham T, Wickens K, et al. Cord-blood 25- hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011;127(1):e180–187.
   PubMed Web of Science ®Google Scholar
• Xie H, Wu L, Deng Z, et al. Emerging roles of YAP/TAZ in lung physiology and diseases. Life Sci. 2018;214:176–183.
   PubMed Web of Science ®Google Scholar
• Yeo MK, Park HS, Park YH, et al. expression pattern of the hippo pathway effector TAZ in cellular and fibrotic nonspecific interstitial pneumonia. Chin Med J (Engl). 2018;131(5):626–628.
   PubMed Web of Science ®Google Scholar